These authors jointly supervised this work: Pedro Berraondo, Ignacio Melero
Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain
Elisabeth Perez-Ruiz, Luna Minute, Itziar Otano, Maite Alvarez, Maria Carmen Ochoa, Virginia Belsue, Maria Esperanza Rodriguez-Ruiz, Carmen Molina, Alvaro Teijeira, Pedro Berraondo & Ignacio Melero
Navarra Institute for Health Research (IDISNA), Pamplona, Spain
Elisabeth Perez-Ruiz, Luna Minute, Itziar Otano, Maite Alvarez, Maria Carmen Ochoa, Virginia Belsue, Carlos de Andrea, Jose Luis Perez-Gracia, Carmen Molina, Alvaro Teijeira, Pedro Berraondo & Ignacio Melero
Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain
Elisabeth Perez-Ruiz, Maria Esperanza Rodriguez-Ruiz, Jose Luis Perez-Gracia & Ignacio Melero
Department of Oncology, Hospital Costa del Sol, Marbella, Spain
Elisabeth Perez-Ruiz
Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
Elisabeth Perez-Ruiz, Martina Alvarez & Vanesa de Luque
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
Maria Carmen Ochoa, Jose Luis Perez-Gracia, Ivan Marquez-Rodas, Alvaro Teijeira, Pedro Berraondo & Ignacio Melero
Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain
Carlos de Andrea
Department of Oncology, Hospital General Universitario Gregorio Marañon, Madrid, Spain
Ivan Marquez-Rodas
Department of Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain
Casilda Llacer
Laboratorio de Biología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain
Martina Alvarez & Vanesa de Luque
Department of Pathology, Faculty of Medicine, Universidad de Málaga, Málaga, Spain
Martina Alvarez
Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain
Ignacio Melero
